Hans Bishop

Hans Bishop

Founder at SANA BIOTECHNOLOGY, INC.

Net worth: 72 M $ as of 2024-03-30

59 year
Health Technology
Finance
Consumer Services

Profile

Mr. Hans E. Bishop is a Chief Executive Officer & Director at GRAIL, Inc., a Chairman at Sana Biotechnology, Inc., an Independent Director at Agilent Technologies, Inc. and a President & Director at X-Body, Inc. He is on the Board of Directors at GRAIL, Inc., JW (Cayman) Therapeutics Co. Ltd., Agilent Technologies, Inc., JW Biotechnology (Shanghai) Co. Ltd., JW Therapeutics (Shanghai) Co., Ltd., Lyell Immunopharma, Inc. and X-Body, Inc. Mr. Bishop was previously employed as a President, Chief Executive Officer & Director by Juno Therapeutics, Inc., an Independent Director by Avanir Pharmaceuticals, Inc., a Chief Operating Officer by PhotoThera, Inc., an Executive Chairman by Lion Biotechnologies, Inc., a President-Specialty Medicine Business by Bayer HealthCare Pharmaceuticals, Inc., a Senior Vice President-Global Commercial Operations by Chiron Corp., a Chief Operating Officer & Executive Vice President by Dendreon Pharmaceuticals, Inc., a Vice President & General Manager by European Biopharmaceutical Enterprises, a Principal by Glaxo Wellcome Plc, a Principal by GlaxoSmithKline LLC, and an Executive-in-Residence by Warburg Pincus LLC. He also served on the board at Celgene Corp. He received his undergraduate degree from Brunel University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-04 5,779,640 ( 2.62% ) 58 M $ 2024-03-30
2023-09-07 4,685,614 ( 1.84% ) 10 M $ 2024-03-30
2024-03-14 24,976 ( 0.01% ) 4 M $ 2024-03-30
0.04%
2020-08-30 280,482 ( 0.04% ) 3 $ 2020-08-30

Hans Bishop active positions

CompaniesPositionStart
AGILENT TECHNOLOGIES, INC. Director/Board Member 2017-07-17
SANA BIOTECHNOLOGY, INC. Founder 2018-07-12
LYELL IMMUNOPHARMA, INC. Director/Board Member 2018-07-31
Director/Board Member -
Founder 2021-11-30
JW Biotechnology (Shanghai) Co. Ltd. Director/Board Member -
Director/Board Member 2020-02-29
All active positions of Hans Bishop

Former positions of Hans Bishop

CompaniesPositionEnd
JW (CAYMAN) THERAPEUTICS CO. LTD Director/Board Member 2021-12-02
Chief Executive Officer 2021-10-13
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Hans Bishop's experience

Training of Hans Bishop

Brunel University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hans Bishop's experience

Connections

98

1st degree connections

24

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
AGILENT TECHNOLOGIES, INC.

Health Technology

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

JW (CAYMAN) THERAPEUTICS CO. LTD

Health Technology

SANA BIOTECHNOLOGY, INC.

Health Technology

LYELL IMMUNOPHARMA, INC.

Health Technology

Private companies18

Health Technology

Health Technology

Finance

Glaxo Wellcome Plc

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

JW Biotechnology (Shanghai) Co. Ltd.

Health Technology

Health Technology

Commercial Services

Health Technology

See company connections